Prostate News Archive
21-Jul-2007
Prostate cancer drug doesn't diminish sexual function in most men (New Kerala)
Washington, July 20 : Men worried about taking finasteride, a drug proven effective in preventing prostate cancer, just because it might effect their performance in the bedroom, can now put their fears to rest, thanks to a new study. Study: Prostate drug won't hurt sexuality (UPI)
Finasteride, a drug that can reduce the incidence of prostate cancer, does not cause long-term sexual dysfunction, say Seattle researchers. (2º) Proxcelan(TM) for Use in Prostate Cancer Brachytherapy (InfoBolsa)
IsoRay Medical, Inc. Introduces Branding of Cesium-131 as . Proxcelan(TM) for Use in Prostate Cancer Brachytherapy 20/07/2007 19:31:00 Business Wire FOOTNOTE: (1) Armpilia CI, Dale RG, Coles IP et al. Merv Griffin Treated for Prostate Cancer (ABC News)
Merv Griffin Hospitalized for a Recurrence of Prostate Cancer, Spokeswoman Says IsoRay Medical, Inc. Introduces Branding of Cesium-131 as Proxcelan(TM) for Use in Prostate Cancer Brachytherapy (Business Wire via Yahoo! Finance)
RICHLAND, Wash.----IsoRay Medical, Inc. begins the brand introduction of its existing proprietary Cesium-131 prostate cancer brachytherapy seeds at the 26th annual American Association of Physicists in Medicine conference in Minneapolis, MN, July 22-26.
Back to Prostate News Archive
